Osteosarcoma

What osteosarcoma is — in plain words

Osteosarcoma is a cancer that starts inside a bone. The cells that normally build new bone start dividing in a disordered way and produce abnormal bone tissue. It is the most common primary bone cancer in children, teenagers and young adults — meaning it starts in the bone itself, rather than spreading there from somewhere else.

Most osteosarcomas grow quickly. That sounds frightening, and it is the reason the treatment is intensive. But fast-growing cancers also tend to be highly responsive to chemotherapy — and that responsiveness is exactly what modern treatment has learned to exploit.

Who tends to get it

Osteosarcoma has a very characteristic age pattern:

• First peak: ages 10 to 25. The classic patient is a tall, growing teenager. It is more common in boys than girls. The link to rapid bone growth at puberty is part of the reason.
• Second peak: over 60. Often connected to a pre-existing bone condition such as Paget's disease, or to bone that has previously been treated with radiation.

Most cases happen for no identifiable reason. A small number are linked to inherited syndromes such as hereditary retinoblastoma or Li-Fraumeni syndrome — your team may discuss genetic counselling if the family pattern suggests it.

Where it usually shows up

The signs that should not be ignored

Most teenage knee pain is not osteosarcoma. But persistent, unexplained bone pain — especially night pain — is worth an X-ray. It is a five-minute investigation that can change a life.

"The hardest conversation in this clinic is telling a 16-year-old and their parents what the next nine months will involve. The next-hardest is, two years later, helping them work out what to do with the rest of a long life. That second conversation happens far more often than the first."

How osteosarcoma is diagnosed

The diagnostic process moves quickly once a suspicious bone is identified.

• Plain X-ray. The first and often the most telling test. Classical signs include a "sunburst" pattern of new bone formation, a "Codman's triangle" where the bone lining is lifted, and a destructive mass that crosses from bone into the surrounding soft tissue.
• MRI of the whole affected bone. The single most important imaging test for surgical planning. It shows the tumour's exact extent inside the bone, whether it has crossed into nearby muscle or joint, and where the nerves and blood vessels lie.
• CT scan of the chest. The lungs are by far the most common place osteosarcoma spreads to. Every patient needs a chest CT at diagnosis.
• Bone scan or PET-CT. To check the rest of the skeleton for other sites of disease.
• Biopsy — at a sarcoma centre. This is non-negotiable. The biopsy track will eventually be removed with the tumour during surgery, so the surgeon who will operate must plan the biopsy. A biopsy done in the wrong place can force an amputation that would otherwise have been avoidable.

How osteosarcoma is treated

Modern osteosarcoma treatment has three stages, and all three are essential. Skipping any one of them substantially worsens the outlook.

Stage 1 — Chemotherapy before surgery (neoadjuvant)

Treatment usually begins with around ten weeks of intensive chemotherapy. The international standard regimen is called MAP: methotrexate (in high doses), doxorubicin (also known as Adriamycin), and cisplatin. The goals are to shrink the tumour, to kill any microscopic cells that may already have escaped, and to make the eventual surgery cleaner and safer.

This is demanding chemotherapy. Inpatient admissions, mouth sores, nausea, hair loss, low blood counts and the risk of infection are all part of it. The team will support you through every cycle — anti-sickness medication, growth factor injections to recover blood counts, transfusions when needed, and a low threshold for admission at the first sign of fever. Read more about chemotherapy →

Stage 2 — Surgery

After the initial chemotherapy, surgery removes the entire tumour with a margin of healthy tissue around it. There are two broad options:

• Limb-sparing surgery. The default for the great majority of patients today. The diseased section of bone is removed and replaced — usually with a metal prosthesis (endoprosthesis), sometimes with a bone graft. Function after recovery is generally excellent, and most patients return to normal walking, school and most sports.
• Amputation. Now reserved for a minority of cases — usually when the tumour involves a critical nerve or vessel that cannot be safely separated, when a young child's growth makes a prosthesis impractical, or when a fracture has spread tumour cells widely. Modern prosthetic limbs, combined with focused rehabilitation, allow a very active life.

The pathologist will then examine the removed tumour and report what proportion of cells were killed by the chemotherapy. A "good response" — usually defined as more than 90% tumour necrosis — is one of the strongest predictors of long-term cure.

Stage 3 — Chemotherapy after surgery (adjuvant)

The remaining months of chemotherapy after surgery complete the treatment. The exact drugs depend on how the tumour responded to the first phase, but the principle is the same: finish the job, eliminate any microscopic cells that might cause a future recurrence.

If the cancer has spread to the lungs

About one in five patients with osteosarcoma has lung metastases at diagnosis. This is harder, but it is not hopeless. The plan still includes intensive chemotherapy and surgery on the primary tumour, plus a separate operation (often by a thoracic surgeon) to remove the lung deposits. A meaningful proportion of patients with limited lung metastases are still cured.

What the outlook honestly looks like

These are averages from international data and they hide a lot of individual variation. Two patients with the same stage can have very different outcomes depending on tumour response, surgical clearance, and how well the chemotherapy is delivered on time. We will always talk you through the specific factors in your case.

Life during the nine months of treatment

There is no way to make osteosarcoma treatment easy. It is one of the most demanding regimens in oncology, deliberately so, and it lasts about nine months from start to finish. What we can do is make it bearable and as safe as possible:

• A central line placed under the skin at the start, so chemotherapy and blood tests do not require repeated needles.
• Aggressive anti-sickness regimens tailored to each cycle.
• A direct phone line for fever or any worrying symptom between cycles — never wait it out at home.
• Nutritional support, sometimes including a feeding tube during the toughest weeks, to keep weight and strength up.
• Physiotherapy that starts early and continues for many months after surgery, so the limb regains its strength.
• Mental health support for the patient and the family. Anxiety, low mood and the social isolation of long hospital admissions are real, and they are treatable.
• School and university liaison so the patient can continue learning — often with online classes during admissions and a planned return when treatment ends.

Fertility — please ask on day one

Some of the chemotherapy used in osteosarcoma — particularly cisplatin and high-dose alkylating agents in older regimens — can affect future fertility. For boys, sperm banking is straightforward and should be discussed before treatment begins. For girls, options are more limited but a fertility specialist consultation is worthwhile. These conversations must happen before chemotherapy starts. Please raise it on your first visit.

After treatment — survivorship

Finishing the last cycle of chemotherapy is a real milestone — and the start of a long chapter of follow-up. We will see you regularly for the first two to three years (the highest-risk period for recurrence), then less frequently for years afterwards. Follow-up includes physical examination, chest CT scans, and imaging of the limb. Most recurrences, when they happen, occur within the first three years.

Long-term survivorship care also pays attention to the late effects of treatment: heart health (because of doxorubicin), hearing (because of cisplatin), kidney function, bone health, fertility, and mental health. Read about survivorship care →

Related services

• Overview of sarcomas
• Ewing sarcoma
• Chondrosarcoma
• Chemotherapy
• Multidisciplinary care
• Second opinion